Sort
40,608 grants matching “prostate cancer”
Shared Resource: Therapeutic Manufacturing
$421,497Ronald Manger · Fred Hutchinson Cancer Research Center · P30 · FY2019 · CA
p53 Variants in Cancer Risk and Therapy
$421,358Maureen E Murphy · Wistar Institute · R01 · FY2017 · CA
COMPUTATIONAL TOOLS FOR CANCER PROTEOMICS
$421,346William Marland Old · University Of Colorado · R01 · FY2008 · CA
Training Program in Cancer Biology
$421,320Mary Elaine Reyland · University Of Colorado Denver · T32 · FY2020 · CA
INCREASING ACCESS TO CLINICAL AND EDUCATIONAL STUDIES
$421,313Thomas Jefferson University · U01 · FY2002 · CA
Shared Resource: Therapeutic Manufacturing
$421,294Ronald Manger · Fred Hutchinson Cancer Research Center · P30 · FY2016 · CA
BIOMAKERS DEVELOPMENT LABORATORY
$421,288University Of Washington · U01 · FY2001 · CA
A Health IT based Psychoeducational Intervention for African American Prostate Ca
$421,250Brian M. Rivers · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2014 · MD
ROLE OF HOMEODOMAIN GENES IN HUMAN PROSTATE CANCER
$421,240University Of Colorado Denver · R01 · FY2000 · CA
Role of the AR-ErbB3-Nrdp1 axis in mediating prostate cancer health disparities
$421,195Ruth Louise Vinall · California Northstate University · R15 · FY2016 · CA
PROMOTING HEALTH IN PROSTATE &BREAST CANCER
$421,100Duke University · R01 · FY2002 · CA
Investigation of Membrane-Bound Cytochromes-P450-b5 Interactions
$421,087Ayyalusamy Ramamoorthy · University Of Michigan At Ann Arbor · R01 · FY2015 · GM
Advancement and Validation of Prostate Diffusion and Spectroscopic MRI
$421,068Stephan E Maier · Brigham And Women'S Hospital · R01 · FY2014 · CA
A study of IDH1-mutant prostate cancer to identify novel therapeutic targets
$421,042Laura A. Sena · Johns Hopkins University · R21 · FY2024 · CA
EXPANDING AN ACTIVE SURVEILLANCE COHORT TO IMPROVE SURVIVORSHIP FOR BLACK MEN WITH FAVORABLE-RISK PROSTATE CANCER
$421,033University Of Illinois · · FY2021 · Defense Health Agency
Cancer-prone cell states of the fallopian tubal epithelium
$420,922Alexander Y Nikitin · Cornell University · R01 · FY2023 · CA
Cancer-prone cell states of the fallopian tubal epithelium
$420,922Alexander Y Nikitin · Cornell University · R01 · FY2022 · CA
Project 2: Effect of HTLV-1 Viral Oncogenes on the Bone Microenvironment during tumor growth and progression in ATL
$420,919Deborah V Novack · Ohio State University · P01 · FY2022 · CA
Genetics of Prostate Cancer Risk &Agressiveness
$420,917Cleveland Clinic Lerner Col/Med-Cwru · R01 · FY2005 · CA
MTA1- targeted strategies for prostate cancer management
$420,900Anait S Levenson · Long Island University Brooklyn Campus · R15 · FY2018 · CA
Project 2: Near-Infrared Targeted Tracers for Intraoperative Identification of NSCLC
$420,841Philip Stewart Low · University Of Pennsylvania · P01 · FY2025 · CA
Nutrition, Metabolism, and Cancer
$420,816Regina G Ziegler · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA
Radiopharmaceuticals for Imaging Nuclear Receptors in Breast and Prostate Cancers
$420,805John A. Katzenellenbogen · University Of Illinois At Urbana-Champaign · R01 · FY2017 · CA
Role of immune cell OGR1 in prostate cancer development and the mechanisms involv
$420,784Yan Xu · Indiana University Indianapolis · R01 · FY2012 · CA
Investigation of Membrane-Bound Cytochromes-P450-b5 Interactions
$420,762Ayyalusamy Ramamoorthy · University Of Michigan At Ann Arbor · R01 · FY2017 · GM